Abstracts

Oral Prenylation Inhibition With Lonafarnib in Chronic Hepatitis D Infection: A Randomized, Double-Blinded, Placebo-Controlled Proof-of-Concept Study

Background: Interferon therapy for chronic delta hepatitis (HDV) infection is unsatisfactory. In in vivo models, prenylation inhibition has proven effectiveness against HDV. In a first-in-human for HDV, proof-of-concept study, we evaluated the antiviral effects and safety of the prenylation inhibitor, lonafarnib (LNF), in patients with chronic HDV. Methods: HDV patients were sequentially enrolled into 2…

Incidence of Hepatitis E Virus in HIV-Infected Patients: A Longitudinal Prospective Study

Background: Hepatitis E virus (HEV) incidence in HIV infected patients has not been well established. Studies reporting HEV seroprevalence and incidence in this populations present several methodological limitations such as retrospective analysis and small population samples. As a result, the current magnitude of this emerging disease in this population cannot be established. Therefore, we designed…

Factors Associated With Extensive Cervical Lesions Among HIV-Infected Women Screening for AIDS Clinical Trials Group (ACTG) Protocol A5282

Background: ‘Screen-and-treat’ approaches for prevention of cervical cancer are used in many resource-constrained settings because of the challenges associated with cytology. Women are screened with: (1) visual inspection after acetic acid (VIA), or (2) testing for high-risk human papillomavirus (hrHPV), followed by treatment with cervical cryotherapy for those screening positive. However, women may have extensive…

HIV Infection and Survival Among Women With Cervical Cancer in Botswana

Background: Cervical cancer is the most common malignancy in African women and incidence has increased with expansion of ART coverage. We sought to prospectively evaluate the association between HIV-infection and survival of patients diagnosed with cervical cancer in a country with high HIV treatment coverage. Methods: We enrolled sequential patients presenting for initial treatment of…

Potential Cost-Effectiveness of Cervical Cancer Screening of HIV-Positive Kenyan Women

Background: As antiretroviral therapy is scaled up in Africa, HIV-positive women are living longer and increasingly likely to die from cervical cancer. Cervical cancer screening methods used in these settings include Papanicolaou smear (Pap), visual inspection with acetic acid (VIA), and human papillomavirus testing (HPV). Our objective was to assess the cost-effectiveness of these methods…

Anal High-Risk Human Papillomavirus (HPV) Infection Among HIV-Infected MSM in the SUN Study, 2004-2011

Background: Incidence and clearance of anal high-risk HPV (HR-HPV) infection in HIV-infected men who have sex with men (MSM) have not been well characterized. These dynamics may have implications for vaccine strategies to reduce anal cancer burden. Methods: The SUN Study is a prospective observational cohort of HIV-infected patients receiving care in four U.S. cities.…

Survival and Treatment Trends for Squamous Cell Carcinoma of the Anus in HIV Infection

Background: HIV seropositive (HIV+) patients are at increased risk of squamous cell carcinoma of the anus (SCCA). Howevere, there are limited data regarding antiretroviral era survival and treatment trends for HIV+ patients with SCCA. Methods: We used data from the Surveillance, Epidemiology, and End Results (SEER) registry linked to Medicare claims to evaluate outcomes among…

Oral HPV Shedding and Warts After Starting Antiretroviral Therapy: ACTG Protocol A5272

Background: Previous studies have suggested an increase in the incidence of oral warts following antiretroviral therapy (ART) initiation. In addition, there are recent reports of an increasing incidence of human papilloma virus(HPV)-related oral malignancies among the US population living with HIV infection, despite the widespread availability of ART for almost two decades. Therefore, we sought…